http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20060004681-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7b85edf4e8b9338b24ad34ce53c7328
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1617
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5026
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-52
filingDate 2004-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eb2da60e44596c117ac765f1f39ebc1
publicationDate 2006-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-20060004681-A
titleOfInvention Compositions for oral administration containing alkylene dioxybenzene derivatives
abstract The present invention relates to oral dosage compositions in which the drug concentration in plasma is maintained for a long time and contains an alkylenedioxybenzene derivative of general formula (I) or an acid addition salt thereof (wherein m is an integer from 2 to 5). N is an integer from 1 to 3). By dispersing the compound of formula (I) in a synthetic polymer and / or wax-containing matrix, stable and useful oral dosage pharmaceutical formulations with stable drug release properties in vivo are obtained.
priorityDate 2003-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID107665
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16682987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449039557
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522148
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18688924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8209
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530015
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID198746
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449000177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451921666
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474364

Total number of triples: 43.